ConductScience.org, home

Paper19906992

Role of HIV membrane in neutralization by two broadly neutralizing antibodies.

Alam SM and 10 others. Proc Natl Acad Sci U S A, 2009. Cited by 223 papers, by iCite.

Cite this record

ConductScience Library. Role of HIV membrane in neutralization by two broadly neutralizing antibodies. Papers, record 19906992. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/19906992

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Role of HIV membrane in neutralization by two broadly neutralizing antibodies.
PubMed
Journal
Proc Natl Acad Sci U S A
PubMed
Year
2009
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
223
iCite
Relative citation ratio, by iCite
4.8
iCite
Revised in PubMed
2021-10-20
PubMed

Authors11

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Alam SMS Munir
2Morelli MMarco
3Dennison SMS Moses
4Liao HXHua-Xin
5Zhang RRuijun
6Xia SMShi-Mao
7Rits-Volloch SSophia
8Sun LLi
9Harrison SCStephen C
10Haynes BFBarton F
11Chen BBing

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antibodies, MonoclonalMajor topic
Antibodies, NeutralizingMajor topic
HIV InfectionsMajor topic
HIV-1Major topic
Models, MolecularMajor topic
Viral VaccinesMajor topic
HIV Envelope Protein gp41
Humans
Membranes, Artificial
Mutation
Neutralization Tests
Protein Binding

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
R21 AI069972NIAID NIH HHSUnited StatesR21AI069972PubMed and NIHNIH RePORTER
Howard Hughes Medical InstituteUnited StatesPubMedPubMed

Download CSV of grants

References36

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
17973652Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody.Science1994https://conductscience.org/library/papers/7973652PubMed
27692082A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1.J Virol1993https://conductscience.org/library/papers/7692082PubMed
312644702Rapid evolution of the neutralizing antibody response to HIV type 1 infection.Proc Natl Acad Sci U S A2003https://conductscience.org/library/papers/12644702PubMed
412860131Structural analysis of the epitope of the anti-HIV antibody 2F5 sheds light into its mechanism of neutralization and HIV fusion.J Mol Biol2003https://conductscience.org/library/papers/12860131PubMed
512379111A monomeric 3(10)-helix is formed in water by a 13-residue peptide representing the neutralizing determinant of HIV-1 on gp41.Biochemistry2002https://conductscience.org/library/papers/12379111PubMed
614990736The long third complementarity-determining region of the heavy chain is important in the activity of the broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2F5.J Virol2004https://conductscience.org/library/papers/14990736PubMed
716481622The HIV lipidome: a raft with an unusual composition.Proc Natl Acad Sci U S A2006https://conductscience.org/library/papers/16481622PubMed
816940516Proteomic and biochemical analysis of purified human immunodeficiency virus type 1 produced from infected monocyte-derived macrophages.J Virol2006https://conductscience.org/library/papers/16940516PubMed
99630213HIV entry and its inhibition.Cell1998https://conductscience.org/library/papers/9630213PubMed
109126269Microvesicles are a source of contaminating cellular proteins found in purified HIV-1 preparations.Virology1997https://conductscience.org/library/papers/9126269PubMed
1117260969Exposure of the membrane-proximal external region of HIV-1 gp41 in the course of HIV-1 envelope glycoprotein-mediated fusion.Biochemistry2007https://conductscience.org/library/papers/17260969PubMed
1217039602A group M consensus envelope glycoprotein induces antibodies that neutralize subsets of subtype B and C HIV-1 primary viruses.Virology2006https://conductscience.org/library/papers/17039602PubMed
139442107Dilation of the human immunodeficiency virus-1 envelope glycoprotein fusion pore revealed by the inhibitory action of a synthetic peptide from gp41.J Cell Biol1998https://conductscience.org/library/papers/9442107PubMed
148551569Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1.J Virol1996https://conductscience.org/library/papers/8551569PubMed
1515860590Cardiolipin polyspecific autoreactivity in two broadly neutralizing HIV-1 antibodies.Science2005https://conductscience.org/library/papers/15860590PubMed
1615307924
Evaluation of the safety, immunogenicity, and protective efficacy of whole inactivated simian immunodeficiency virus (SIV) vaccines with conformationally and functionally intact envelope glycoproteins.
AIDS Res Hum Retroviruses2004https://conductscience.org/library/papers/15307924PubMed
1712478295HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites.Nature2002https://conductscience.org/library/papers/12478295PubMed
1811788027A potent cross-clade neutralizing human monoclonal antibody against a novel epitope on gp41 of human immunodeficiency virus type 1.AIDS Res Hum Retroviruses2001https://conductscience.org/library/papers/11788027PubMed
199126268Cell membrane vesicles are a major contaminant of gradient-enriched human immunodeficiency virus type-1 preparations.Virology1997https://conductscience.org/library/papers/9126268PubMed
209108481Core structure of gp41 from the HIV envelope glycoprotein.Cell1997https://conductscience.org/library/papers/9108481PubMed

See all 36 referencesDownload CSV of references

Cited by187

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 223 citations.

PMIDTitleJournalYearIn PapersSource
42931443Advances in HIV-1 Envelope-Based Vaccine Development.Vaccines (Basel)2026https://conductscience.org/library/papers/42931443PubMed
42536668htrSPRanalysis: An open source R package for expedited analysis of high-throughput binding kinetics data.PLoS Comput Biol2026https://conductscience.org/library/papers/42536668PubMed
42446980Structural basis of membrane engagement and polyreactivity control in HIV-1 MPER broadly neutralizing antibodies.Proc Natl Acad Sci U S A2026https://conductscience.org/library/papers/42446980PubMed
42360802Conformational variability of HIV-1 Env trimer and viral vulnerability.Elife2026https://conductscience.org/library/papers/42360802PubMed
41583464Viral glycoprotein-mediated entry and antibody-mediated immunity in HIV-1 and SARS-CoV-2 infection.Front Immunol2025https://conductscience.org/library/papers/41583464PubMed
41545420Heterologous immunization modulates B-cell epitope competition between helper peptides and the MPER segment in MPER/liposome vaccines.NPJ Vaccines2026https://conductscience.org/library/papers/41545420PubMed
41421345Probing the role of membrane in neutralizing activity of antibodies against influenza virus.Structure2026https://conductscience.org/library/papers/41421345PubMed
41280106Conformational Variability of HIV-1 Env Trimer and Viral Vulnerability.bioRxiv2025https://conductscience.org/library/papers/41280106PubMed
40511646Germline-Targeting Strategies to Induce bNAbs against HIV-1.Curr HIV Res2026https://conductscience.org/library/papers/40511646PubMed
40192122Ab initio prediction of specific phospholipid complexes and membrane association of HIV-1 MPER antibodies by multi-scale simulations.Elife2025https://conductscience.org/library/papers/40192122PubMed
39216479Decoupling HIV-1 antiretroviral drug inhibition from plasma antibody activity to evaluate broadly neutralizing antibody therapeutics and vaccines.Cell Rep Med2024https://conductscience.org/library/papers/39216479PubMed
38761800Vaccine induction of heterologous HIV-1-neutralizing antibody B cell lineages in humans.Cell2024https://conductscience.org/library/papers/38761800PubMed
38201237
Determination of Binding Affinity of Antibodies to HIV-1 Recombinant Envelope Glycoproteins, Pseudoviruses, Infectious Molecular Clones, and Cell-Expressed Trimeric gp160 Using Microscale Thermophoresis.
Cells2023https://conductscience.org/library/papers/38201237PubMed
37940661Inadequate structural constraint on Fab approach rather than paratope elicitation limits HIV-1 MPER vaccine utility.Nat Commun2023https://conductscience.org/library/papers/37940661PubMed
37632074Current ARTs, Virologic Failure, and Implications for AIDS Management: A Systematic Review.Viruses2023https://conductscience.org/library/papers/37632074PubMed
37549723Parameter estimation and identifiability analysis for a bivalent analyte model of monoclonal antibody-antigen binding.Anal Biochem2023https://conductscience.org/library/papers/37549723PubMed
36541800Enhancing HIV-1 Neutralization by Increasing the Local Concentration of Membrane-Proximal External Region-Directed Broadly Neutralizing Antibodies.J Virol2023https://conductscience.org/library/papers/36541800PubMed
36479128Autoreactivity and broad neutralization of antibodies against HIV-1 are governed by distinct mutations: Implications for vaccine design strategies.Front Immunol2022https://conductscience.org/library/papers/36479128PubMed
36142694Functional Delineation of a Protein-Membrane Interaction Hotspot Site on the HIV-1 Neutralizing Antibody 10E8.Int J Mol Sci2022https://conductscience.org/library/papers/36142694PubMed
34505005Focal accumulation of aromaticity at the CDRH3 loop mitigates 4E10 polyreactivity without altering its HIV neutralization profile.iScience2021https://conductscience.org/library/papers/34505005PubMed

See all 187 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/19906992

GET https://conductscience.org/api/papers/v1/19906992/references?page=2